Atrial Fibrillation (AFib) is a prevalent condition in the United States that increases with aging. AFib is associated with shorter life spans, a lifelong increased risk of adverse cardiac events including stroke and an overall significantly decreased quality of life.
Depending on individual risk, Coumadin may be indicated for stroke prevention, albeit with a 1% annual risk of either a clinically significant bleeding or thrombotic event. Treatment of AFib ranges from catheter ablation in the Electrophysiology Lab, to open heart procedures that can treat the most difficult patient subsets.
Surgeons at Valley Hospital are proficient in performing extensive bi-atrial Maze surgery (Cox-Maze III) as well as less invasive iterations of the procedure. We have access to the most up-to-date technologies for destroying or trapping AFib signals, including radiofrequency, cryothermy, and high-intensity focused ultrasound.
Soon, we hope to be able to offer patients the opportunity to enroll in a prospective database specifically geared towards patients who have advanced forms of AFib and are usually not offered an intervention. By objectively tracking our outcomes utilizing implantable loop recorders (ILRs), we will find the patient subsets that will benefit from aggressive treatment of their condition.